10/14/2026
Pharma bro Martin Shkreli, the namesake of our annual awards for the most egregious examples of profiteering and dysfunction in healthcare, is back in the news and just in time for our 10th awards show!
The Federal Trade Commission and a coalition of seven states asked a federal court on Tuesday to punish Martin Shkreli for “flagrantly and repeatedly” violating a lifetime ban from being involved in the pharmaceutical industry. In a court filing in the U.S. District Court for the Southern District of New York, the FTC said Shkreli has traded in at least 60 pharmaceutical stocks since being released from prison in 2022.
A leopard, it seems, cannot change its spots.
Submit your nomination by 10/31 for this year's awards at https://lowninstitute.org/shkreli-award-nominations/